These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17109386)

  • 21. Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia.
    Athar U; Husain J; Hudson J; Lynch J; Gajra A
    Am J Hematol; 2008 Mar; 83(3):245-6. PubMed ID: 17910040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
    Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
    Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
    Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case review: anticoagulation in hemodialysis patients with heparin-induced thrombocytopenia.
    Chuang P; Parikh C; Reilly RF
    Am J Nephrol; 2001; 21(3):226-31. PubMed ID: 11423693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of lepirudin during percutaneous vascular interventions in patients with heparin-induced thrombocytopenia.
    Cochran K; DeMartini TJ; Lewis BE; O Brien J; Steen LH; Grassman ED; Leya F
    J Invasive Cardiol; 2003 Nov; 15(11):617-21. PubMed ID: 14608129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lepirudin as a safe alternative for effective anticoagulation in patients with known heparin-induced thrombocytopenia undergoing percutaneous coronary intervention: case reports.
    Manfredi JA; Wall RP; Sane DC; Braden GA
    Catheter Cardiovasc Interv; 2001 Apr; 52(4):468-72. PubMed ID: 11285599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extremely low doses of lepirudin in a patient with heparin-induced thrombocytopenia, high bleeding risk and renal insufficiency.
    Tardy-Poncet B; Charier D; Diconne E; Zeni F; Garraud O; Tardy B; Campos L
    Br J Haematol; 2009 Aug; 146(4):456-7. PubMed ID: 19519692
    [No Abstract]   [Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia type II: a serious hazard in preemptive renal transplantation: a case report.
    Dracopoulos S; Vougas V; Kassimatis TI; Theodoridis T; Ali ME; Apostolou T
    Transplant Proc; 2007 Dec; 39(10):3481-4. PubMed ID: 18089414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hirudin in heparin-induced thrombocytopenia.
    Lubenow N; Greinacher A
    Semin Thromb Hemost; 2002 Oct; 28(5):431-8. PubMed ID: 12420238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence of thrombocytopenia associated with continuous renal replacement therapy in critically ill patients.
    Ferreira JA; Johnson DW
    Ren Fail; 2015 Aug; 37(7):1232-6. PubMed ID: 26108135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bidirectional glenn shunt surgery using lepirudin anticoagulation in an infant with heparin-induced thrombocytopenia with thrombosis.
    Iannoli ED; Eaton MP; Shapiro JR
    Anesth Analg; 2005 Jul; 101(1):74-6, table of contents. PubMed ID: 15976209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bivalirudin anticoagulation for a patient with hypercoagulable immune syndromes undergoing mitral valve surgery.
    Cain RL; Spiess BD; Nelson M; Deanda A; McCarthy HL; Green JA
    Ann Thorac Surg; 2006 Jun; 81(6):2308-10. PubMed ID: 16731183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients.
    Tschudi M; Lämmle B; Alberio L
    Blood; 2009 Mar; 113(11):2402-9. PubMed ID: 19059879
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination platelet glycoprotein IIb/IIIa receptor and lepirudin administration during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.
    Pinto DS; Sperling RT; Tu TM; Cohen DJ; Carrozza JP
    Catheter Cardiovasc Interv; 2003 Jan; 58(1):65-8. PubMed ID: 12508198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excessive anticoagulation and anaphylactic reaction after rechallenge with lepirudin in a patient with heparin-induced thrombocytopenia.
    Badger NO; Butler K; Hallman LC
    Pharmacotherapy; 2004 Dec; 24(12):1800-3. PubMed ID: 15585446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heparin-induced thrombocytopenia in the cardiovascular patient: diagnostic and treatment guidelines.
    Gurbuz AT; Elliott WG; Zia AA
    Eur J Cardiothorac Surg; 2005 Jan; 27(1):138-49. PubMed ID: 15621486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G; Bucha E; Brauns I; Czerwinski R
    Wien Klin Wochenschr; 1997 May; 109(10):354-8. PubMed ID: 9200807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy.
    Hassell K
    Chest; 2005 Feb; 127(2 Suppl):1S-8S. PubMed ID: 15706025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Essentials of anticoagulation in hemodialysis.
    Fischer KG
    Hemodial Int; 2007 Apr; 11(2):178-89. PubMed ID: 17403168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citrate anticoagulation for continuous renal replacement therapy in the critically ill.
    Oudemans-van Straaten HM
    Blood Purif; 2010; 29(2):191-6. PubMed ID: 20093826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.